syndrome	score	normalized_score
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.11728383999999999	100.0
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.11728383999999999	100.0
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.11111099999999999	94.73683672021653
BUERGER DISEASE	0.11111099999999999	94.73683672021653
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.11111099999999999	94.73683672021653
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.11111099999999999	94.73683672021653
CLUSTER HEADACHE, FAMILIAL	0.11111099999999999	94.73683672021653
#615040 EPISODIC PAIN SYNDROME, FAMILIAL, 1; FEPS1	0.11111099999999999	94.73683672021653
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.11111099999999999	94.73683672021653
WILLIAMS-BEUREN SYNDROME; WBS	0.09274361000000002	79.07620521292621
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.09274361000000002	79.07620521292621
ANAL SPHINCTER DYSPLASIA; ASDP	0.09153002000000002	78.04145907910248
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.09153002000000002	78.04145907910248
300270 ADRENOMYODYSTROPHY	0.09153002000000002	78.04145907910248
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.08454689000000001	72.08741630560529
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.08454689000000001	72.08741630560529
CURRARINO SYNDROME	0.08333330000000001	71.05267017178157
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.08333330000000001	71.05267017178157
CURRY-JONES SYNDROME	0.08333330000000001	71.05267017178157
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.08333330000000001	71.05267017178157
TURNPENNY-FRY SYNDROME; TPFS	0.08333330000000001	71.05267017178157
Yao syndrome	0.0403846	34.43321773911905
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.03319672	28.304598485179206
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.02981851	25.42422724221854
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.02981851	25.42422724221854
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.02981851	25.42422724221854
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.02981851	25.42422724221854
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.02981851	25.42422724221854
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.02860492	24.38948110839482
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.026581039999999997	22.66385548085738
ALSTROM SYNDROME; ALMS	0.026213590000000002	22.350555711682023
CASPASE 8 DEFICIENCY	0.026213590000000002	22.350555711682023
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.026213590000000002	22.350555711682023
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.026213590000000002	22.350555711682023
SECKEL SYNDROME 9; SCKL9	0.026213590000000002	22.350555711682023
CHROMOSOME 18Q DELETION SYNDROME	0.026213590000000002	22.350555711682023
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.026213590000000002	22.350555711682023
IMMUNODEFICIENCY 58; IMD58	0.026213590000000002	22.350555711682023
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.026213590000000002	22.350555711682023
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.026213590000000002	22.350555711682023
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.026213590000000002	22.350555711682023
ICHTHYOSIS VULGARIS	0.025	21.3158095778583
NETHERTON SYNDROME; NETH	0.025	21.3158095778583
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.025	21.3158095778583
DERMATITIS, ATOPIC	0.025	21.3158095778583
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.025	21.3158095778583
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.025	21.3158095778583
IMMUNODEFICIENCY 23; IMD23	0.025	21.3158095778583
#170100 PROLIDASE DEFICIENCY	0.025	21.3158095778583
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.025	21.3158095778583
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.025	21.3158095778583
IGE RESPONSIVENESS, ATOPIC	0.025	21.3158095778583
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.025	21.3158095778583
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.025	21.3158095778583
NEUTROPHIL CHEMOTACTIC RESPONSE	0.025	21.3158095778583
MUCOPOLYSACCHARIDOSIS, TYPE II	0.025	21.3158095778583
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.025	21.3158095778583
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	0.025	21.3158095778583
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.025	21.3158095778583
CYSTIC FIBROSIS	0.025	21.3158095778583
TRANSALDOLASE DEFICIENCY	0.025	21.3158095778583
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.025	21.3158095778583
BARDET-BIEDL SYNDROME 1; BBS1	0.025	21.3158095778583
ASTHMA, SUSCEPTIBILITY TO	0.025	21.3158095778583
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.025	21.3158095778583
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.025	21.3158095778583
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.025	21.3158095778583
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.025	21.3158095778583
ADIPOSIS DOLOROSA	0.02358132	20.106197068581658
GITELMAN SYNDROME	0.02358132	20.106197068581658
ROIFMAN SYNDROME; RFMN	0.02162179	18.43543833489763
Diamond-Blackfan anemia 1	0.02162179	18.43543833489763
CORNEODERMATOOSSEOUS SYNDROME	0.02162179	18.43543833489763
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.02162179	18.43543833489763
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.02162179	18.43543833489763
TEMPLE SYNDROME	0.02162179	18.43543833489763
COSTELLO SYNDROME; CSTLO	0.02162179	18.43543833489763
TYSHCHENKO SYNDROME	0.02162179	18.43543833489763
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.02162179	18.43543833489763
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.02162179	18.43543833489763
RESTRICTIVE DERMOPATHY, LETHAL	0.020408199999999998	17.40069220107391
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	17.40069220107391
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	17.40069220107391
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	17.40069220107391
INFANTILE SIALIC ACID STORAGE DISEASE	0.020408199999999998	17.40069220107391
GAUCHER DISEASE, PERINATAL LETHAL	0.020408199999999998	17.40069220107391
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	17.40069220107391
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	17.40069220107391
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.020408199999999998	17.40069220107391
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.020408199999999998	17.40069220107391
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.020408199999999998	17.40069220107391
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.020408199999999998	17.40069220107391
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	17.40069220107391
KAGAMI-OGATA SYNDROME	0.020408199999999998	17.40069220107391
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.020408199999999998	17.40069220107391
KNIEST-LIKE DYSPLASIA, LETHAL	0.020408199999999998	17.40069220107391
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.020408199999999998	17.40069220107391
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	17.40069220107391
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	17.40069220107391
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	17.40069220107391
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.020408199999999998	17.40069220107391
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	17.40069220107391
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	17.40069220107391
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.020408199999999998	17.40069220107391
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.020408199999999998	17.40069220107391
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.020408199999999998	17.40069220107391
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.020408199999999998	17.40069220107391
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.020408199999999998	17.40069220107391
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	17.40069220107391
NEMALINE MYOPATHY 10	0.020408199999999998	17.40069220107391
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.020408199999999998	17.40069220107391
YUNIS-VARON SYNDROME	0.020408199999999998	17.40069220107391
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.01659819	14.152154295084474
MUCOLIPIDOSIS III GAMMA	0.01659819	14.152154295084474
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.01659819	14.152154295084474
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.01659819	14.152154295084474
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.01659819	14.152154295084474
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.01659819	14.152154295084474
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.01659819	14.152154295084474
#307800 HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR;;HYPOPHOSPHATEMIA, X-LINKED; XLH;;HYP;;VITAMIN D-RESISTANT RICKETS, X-LINKED;;HYPOPHOSPHATEMIC VITAMIN D-RESISTANT RICKETS; HPDR	0.01659819	14.152154295084474
MEVALONIC ACIDURIA; MEVA	0.01659819	14.152154295084474
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.01659819	14.152154295084474
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.01659819	14.152154295084474
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.01659819	14.152154295084474
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.01659819	14.152154295084474
LOWE OCULOCEREBRORENAL SYNDROME	0.01558315	13.286698320928103
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.0153846	13.117408161260752
HEMOCHROMATOSIS, TYPE 4; HFE4	0.0153846	13.117408161260752
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.0153846	13.117408161260752
UPINGTON DISEASE	0.0153846	13.117408161260752
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0153846	13.117408161260752
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.0153846	13.117408161260752
COMPLEMENT COMPONENT C1R DEFICIENCY	0.0153846	13.117408161260752
%613944 IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.0153846	13.117408161260752
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.0153846	13.117408161260752
IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.0153846	13.117408161260752
FAMILIAL MEDITERRANEAN FEVER; FMF	0.0153846	13.117408161260752
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.0153846	13.117408161260752
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.0153846	13.117408161260752
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0153846	13.117408161260752
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.0153846	13.117408161260752
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0153846	13.117408161260752
CZECH DYSPLASIA, METATARSAL TYPE	0.0153846	13.117408161260752
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	0.0153846	13.117408161260752
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.0153846	13.117408161260752
PSEUDOACHONDROPLASIA	0.0153846	13.117408161260752
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2	0.0153846	13.117408161260752
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0153846	13.117408161260752
SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM	0.0153846	13.117408161260752
#615399 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2	0.0153846	13.117408161260752
#134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT	0.0153846	13.117408161260752
HAND OSTEOARTHRITIS	0.0153846	13.117408161260752
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.0153846	13.117408161260752
MAJEED SYNDROME	0.0153846	13.117408161260752
#313400 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT;;SED TARDA, X-LINKED;;SPONDYLOEPIPHYSEAL DYSPLASIA, LATE	0.0153846	13.117408161260752
ALKAPTONURIA	0.0153846	13.117408161260752
HYPER-IGD SYNDROME	0.0153846	13.117408161260752
EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5	0.0153846	13.117408161260752
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0153846	13.117408161260752
SITOSTEROLEMIA	0.0153846	13.117408161260752
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.0153846	13.117408161260752
PYLE DISEASE; PYL	0.0153846	13.117408161260752
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0153846	13.117408161260752
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.0153846	13.117408161260752
CHILBLAIN LUPUS 1	0.0153846	13.117408161260752
SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	0.0153846	13.117408161260752
STICKLER SYNDROME, TYPE III	0.0153846	13.117408161260752
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.0153846	13.117408161260752
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.0153846	13.117408161260752
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.0153846	13.117408161260752
#614878 AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED;APLAID	0.0153846	13.117408161260752
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.0153846	13.117408161260752
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.0153846	13.117408161260752
#614135 EPIPHYSEAL DYSPLASIA, MULTIPLE, 6; EDM6	0.0153846	13.117408161260752
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.01436956	12.25195218710438
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.01436956	12.25195218710438
CHROMOSOME 1P36 DELETION SYNDROME	0.01436956	12.25195218710438
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.01436956	12.25195218710438
WIEDEMANN-STEINER SYNDROME; WDSTS	0.00941031	8.02353504114463
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00941031	8.02353504114463
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00941031	8.02353504114463
MOWAT-WILSON SYNDROME; MOWS	0.00941031	8.02353504114463
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.00941031	8.02353504114463
COFFIN-SIRIS SYNDROME 7; CSS7	0.00941031	8.02353504114463
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00941031	8.02353504114463
PROPIONIC ACIDEMIA	0.00941031	8.02353504114463
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.00941031	8.02353504114463
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00941031	8.02353504114463
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.00941031	8.02353504114463
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00941031	8.02353504114463
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00941031	8.02353504114463
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00941031	8.02353504114463
SMITH-MAGENIS SYNDROME; SMS	0.00941031	8.02353504114463
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00941031	8.02353504114463
WHITE-SUTTON SYNDROME; WHSUS	0.00941031	8.02353504114463
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.00941031	8.02353504114463
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00941031	8.02353504114463
NIEMANN-PICK DISEASE, TYPE A	0.00941031	8.02353504114463
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00941031	8.02353504114463
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.00941031	8.02353504114463
COFFIN-SIRIS SYNDROME 6; CSS6	0.00941031	8.02353504114463
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00941031	8.02353504114463
RETT SYNDROME; RTT	0.00941031	8.02353504114463
SCHAAF-YANG SYNDROME; SHFYNG	0.00941031	8.02353504114463
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00819672	6.988788907320906
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.00819672	6.988788907320906
HOLOPROSENCEPHALY 2; HPE2	0.00819672	6.988788907320906
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00819672	6.988788907320906
EMANUEL SYNDROME	0.00819672	6.988788907320906
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00819672	6.988788907320906
CHROMOSOME 19p13.13 DELETION SYNDROME	0.00819672	6.988788907320906
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00819672	6.988788907320906
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00819672	6.988788907320906
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.00819672	6.988788907320906
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00819672	6.988788907320906
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.00819672	6.988788907320906
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00819672	6.988788907320906
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00819672	6.988788907320906
KAPUR-TORIELLO SYNDROME	0.00819672	6.988788907320906
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00819672	6.988788907320906
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00819672	6.988788907320906
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00819672	6.988788907320906
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.00819672	6.988788907320906
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00819672	6.988788907320906
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00819672	6.988788907320906
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00819672	6.988788907320906
AUTISM, SUSCEPTIBILITY TO, 18	0.00819672	6.988788907320906
Glycosylphosphatidylinositol biosynthesis defect 18	0.00819672	6.988788907320906
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00819672	6.988788907320906
PORPHYRIA VARIEGATA	0.00819672	6.988788907320906
611961 STEVENSON-CAREY SYNDROME	0.00819672	6.988788907320906
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00819672	6.988788907320906
Xq28 (MECP2) duplication	0.00819672	6.988788907320906
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.00819672	6.988788907320906
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00819672	6.988788907320906
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00819672	6.988788907320906
UROFACIAL SYNDROME	0.00819672	6.988788907320906
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.00819672	6.988788907320906
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00819672	6.988788907320906
ERYTHERMALGIA, PRIMARY	0.00819672	6.988788907320906
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00819672	6.988788907320906
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00819672	6.988788907320906
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00819672	6.988788907320906
HYPOPHOSPHATASIA, INFANTILE	0.00819672	6.988788907320906
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00819672	6.988788907320906
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.00819672	6.988788907320906
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00819672	6.988788907320906
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.00819672	6.988788907320906
PITT-HOPKINS SYNDROME	0.00819672	6.988788907320906
DESANTO-SHINAWI SYNDROME	0.00819672	6.988788907320906
RETT SYNDROME, CONGENITAL VARIANT	0.00819672	6.988788907320906
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00819672	6.988788907320906
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00819672	6.988788907320906
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.00819672	6.988788907320906
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.00819672	6.988788907320906
AU-KLINE SYNDROME; AUKS	0.00819672	6.988788907320906
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00819672	6.988788907320906
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.00819672	6.988788907320906
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00819672	6.988788907320906
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00819672	6.988788907320906
MYXEDEMA	0.00819672	6.988788907320906
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.00819672	6.988788907320906
PARKINSON DISEASE, LATE-ONSET; PD	0.00819672	6.988788907320906
FG SYNDROME 2; FGS2	0.00819672	6.988788907320906
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00819672	6.988788907320906
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00819672	6.988788907320906
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00819672	6.988788907320906
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00819672	6.988788907320906
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00819672	6.988788907320906
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00819672	6.988788907320906
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00819672	6.988788907320906
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00819672	6.988788907320906
UROFACIAL SYNDROME 2	0.00819672	6.988788907320906
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.00819672	6.988788907320906
ANGELMAN SYNDROME	0.00819672	6.988788907320906
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00819672	6.988788907320906
VISCERAL MYOPATHY; VSCM	0.00819672	6.988788907320906
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.00819672	6.988788907320906
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.00819672	6.988788907320906
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00819672	6.988788907320906
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.00819672	6.988788907320906
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.007386429999999999	6.2979094136071945
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.007386429999999999	6.2979094136071945
Helsmoortel-van der Aa syndrome	0.007386429999999999	6.2979094136071945
COFFIN-SIRIS SYNDROME 3; CSS3	0.007386429999999999	6.2979094136071945
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.007386429999999999	6.2979094136071945
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.007386429999999999	6.2979094136071945
COFFIN-SIRIS SYNDROME 1; CSS1	0.007386429999999999	6.2979094136071945
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.007386429999999999	6.2979094136071945
CHROMOSOME Xp11.3 DELETION SYNDROME	0.007386429999999999	6.2979094136071945
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.007386429999999999	6.2979094136071945
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.007386429999999999	6.2979094136071945
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.007386429999999999	6.2979094136071945
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.007386429999999999	6.2979094136071945
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.007386429999999999	6.2979094136071945
COHEN SYNDROME	0.007386429999999999	6.2979094136071945
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.007386429999999999	6.2979094136071945
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.007386429999999999	6.2979094136071945
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.007386429999999999	6.2979094136071945
COFFIN-SIRIS SYNDROME 4; CSS4	0.007386429999999999	6.2979094136071945
COFFIN-SIRIS SYNDROME 2; CSS2	0.007386429999999999	6.2979094136071945
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.007386429999999999	6.2979094136071945
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.007386429999999999	6.2979094136071945
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.007386429999999999	6.2979094136071945
GILLESPIE SYNDROME; GLSP	0.00617284	5.263163279783472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.00617284	5.263163279783472
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.00617284	5.263163279783472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00617284	5.263163279783472
#300071 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A;;CSNB, INCOMPLETE, X-LINKED;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2; CSNB2	0.00617284	5.263163279783472
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00617284	5.263163279783472
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.00617284	5.263163279783472
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00617284	5.263163279783472
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00617284	5.263163279783472
BLUE CONE MONOCHROMACY; BCM	0.00617284	5.263163279783472
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00617284	5.263163279783472
#613758 RETINITIS PIGMENTOSA 47; RP47	0.00617284	5.263163279783472
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00617284	5.263163279783472
#614180 RETINITIS PIGMENTOSA 61; RP61	0.00617284	5.263163279783472
TANGIER DISEASE; TGD	0.00617284	5.263163279783472
CONE-ROD DYSTROPHY 17; CORD17	0.00617284	5.263163279783472
FUMARASE DEFICIENCY; FMRD	0.00617284	5.263163279783472
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00617284	5.263163279783472
#606952 ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B;;OCULOCUTANEOUS ALBINISM, TYPE IB;;ALBINISM, YELLOW MUTANT TYPE;;YELLOW ALBINISMALBINISM, OCULOCUTANEOUS, TYPE I, TEMPERATURE-SENSITIVE, INCLUDED;;OCA1-TS, INCLUDED	0.00617284	5.263163279783472
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00617284	5.263163279783472
#613428 RETINITIS PIGMENTOSA 54; RP54	0.00617284	5.263163279783472
#615431 MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23	0.00617284	5.263163279783472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00617284	5.263163279783472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00617284	5.263163279783472
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00617284	5.263163279783472
HYPERTRYPTOPHANEMIA; HYPTRP	0.00617284	5.263163279783472
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00617284	5.263163279783472
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00617284	5.263163279783472
ALBINISM, OCULAR, TYPE I	0.00617284	5.263163279783472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.00617284	5.263163279783472
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00617284	5.263163279783472
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00617284	5.263163279783472
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00617284	5.263163279783472
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00617284	5.263163279783472
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00617284	5.263163279783472
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.00617284	5.263163279783472
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.00617284	5.263163279783472
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00617284	5.263163279783472
CROUZON SYNDROME	0.00617284	5.263163279783472
JOUBERT SYNDROME 2	0.00617284	5.263163279783472
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00617284	5.263163279783472
#610359 RETINITIS PIGMENTOSA 33; RP33	0.00617284	5.263163279783472
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00617284	5.263163279783472
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00617284	5.263163279783472
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.00617284	5.263163279783472
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.00617284	5.263163279783472
PEROXISOME BIOGENESIS DISORDER 6B	0.00617284	5.263163279783472
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00617284	5.263163279783472
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.00617284	5.263163279783472
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.00617284	5.263163279783472
BIRDSHOT CHORIORETINOPATHY	0.00617284	5.263163279783472
JOUBERT SYNDROME 3; JBTS3	0.00617284	5.263163279783472
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.00617284	5.263163279783472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00617284	5.263163279783472
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00617284	5.263163279783472
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00617284	5.263163279783472
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00617284	5.263163279783472
BAKER-GORDON SYNDROME; BAGOS	0.00617284	5.263163279783472
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00617284	5.263163279783472
CONE DYSTROPHY 4	0.00617284	5.263163279783472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.00617284	5.263163279783472
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00617284	5.263163279783472
MUCOLIPIDOSIS IV; ML4	0.00617284	5.263163279783472
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.00617284	5.263163279783472
#610427 CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY; CSNB2B,FORMERLY;;NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE,FORMERLY	0.00617284	5.263163279783472
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.00617284	5.263163279783472
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00617284	5.263163279783472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00617284	5.263163279783472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00617284	5.263163279783472
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00617284	5.263163279783472
#613856 ACHROMATOPSIA 4; ACHM4	0.00617284	5.263163279783472
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.00617284	5.263163279783472
#613827 RETINITIS PIGMENTOSA 48; RP48	0.00617284	5.263163279783472
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.00617284	5.263163279783472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00617284	5.263163279783472
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.00617284	5.263163279783472
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00617284	5.263163279783472
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00617284	5.263163279783472
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00617284	5.263163279783472
SPASTIC PARAPLEGIA 16, X-LINKED	0.00617284	5.263163279783472
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.00617284	5.263163279783472
#613268 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.00617284	5.263163279783472
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00617284	5.263163279783472
#165550 OPTIC NERVE HYPOPLASIA, BILATERALOPTIC NERVE APLASIA, BILATERAL, INCLUDED	0.00617284	5.263163279783472
RETINAL CONE DYSTROPHY 4	0.00617284	5.263163279783472
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00617284	5.263163279783472
RETINITIS PIGMENTOSA 27; RP27	0.00617284	5.263163279783472
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00617284	5.263163279783472
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00617284	5.263163279783472
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00617284	5.263163279783472
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00617284	5.263163279783472
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.00617284	5.263163279783472
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00617284	5.263163279783472
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00617284	5.263163279783472
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00617284	5.263163279783472
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.00617284	5.263163279783472
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00617284	5.263163279783472
RETINITIS PIGMENTOSA 20	0.00617284	5.263163279783472
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00617284	5.263163279783472
HEART AND BRAIN MALFORMATION SYNDROME	0.00617284	5.263163279783472
CREUTZFELDT-JAKOB DISEASE; CJD	0.00617284	5.263163279783472
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.00617284	5.263163279783472
#612775 CONE-ROD DYSTROPHY 9; CORD9	0.00617284	5.263163279783472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00617284	5.263163279783472
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.00617284	5.263163279783472
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00617284	5.263163279783472
PEROXISOME BIOGENESIS DISORDER 5B	0.00617284	5.263163279783472
#613829 LEBER CONGENITAL AMAUROSIS 7; LCA7	0.00617284	5.263163279783472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00617284	5.263163279783472
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.00617284	5.263163279783472
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.00617284	5.263163279783472
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.00617284	5.263163279783472
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00617284	5.263163279783472
#608471 CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A;;LATTICE CORNEAL DYSTROPHY, TYPE IIIA	0.00617284	5.263163279783472
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.00617284	5.263163279783472
#607921 RETINITIS PIGMENTOSA 30; RP30	0.00617284	5.263163279783472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00617284	5.263163279783472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.00617284	5.263163279783472
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00617284	5.263163279783472
#606574 ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4;;OCULOCUTANEOUS ALBINISM, TYPE IV	0.00617284	5.263163279783472
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.00617284	5.263163279783472
FILIPPI SYNDROME; FLPIS	0.00617284	5.263163279783472
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00617284	5.263163279783472
JABERI-ELAHI SYNDROME; JABELS	0.00617284	5.263163279783472
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00617284	5.263163279783472
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.00617284	5.263163279783472
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00617284	5.263163279783472
N SYNDROME	0.00617284	5.263163279783472
XFE PROGEROID SYNDROME; XFEPS	0.00617284	5.263163279783472
#603649 CONE-ROD DYSTROPHY 7; CORD7	0.00617284	5.263163279783472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00617284	5.263163279783472
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00121359	1.0347461338237223
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.00121359	1.0347461338237223
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00121359	1.0347461338237223
#612649 CILIARY DYSKINESIA, PRIMARY, 11; CILD11	0.00121359	1.0347461338237223
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00121359	1.0347461338237223
#300555 DENT DISEASE 2	0.00121359	1.0347461338237223
LARSEN-LIKE SYNDROME	0.00121359	1.0347461338237223
SPONDYLOPERIPHERAL DYSPLASIA	0.00121359	1.0347461338237223
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.00121359	1.0347461338237223
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00121359	1.0347461338237223
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00121359	1.0347461338237223
NOONAN SYNDROME 10; NS10	0.00121359	1.0347461338237223
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.00121359	1.0347461338237223
PFEIFFER-PALM-TELLER SYNDROME	0.00121359	1.0347461338237223
NOONAN SYNDROME 6; NS6	0.00121359	1.0347461338237223
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.00121359	1.0347461338237223
STEEL SYNDROME; STLS	0.00121359	1.0347461338237223
RAINE SYNDROME	0.00121359	1.0347461338237223
NOONAN SYNDROME 11; NS11	0.00121359	1.0347461338237223
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00121359	1.0347461338237223
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00121359	1.0347461338237223
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.00121359	1.0347461338237223
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00121359	1.0347461338237223
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00121359	1.0347461338237223
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00121359	1.0347461338237223
CRANIOECTODERMAL DYSPLASIA 4	0.00121359	1.0347461338237223
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00121359	1.0347461338237223
ATKIN-FLAITZ SYNDROME	0.00121359	1.0347461338237223
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.00121359	1.0347461338237223
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00121359	1.0347461338237223
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00121359	1.0347461338237223
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.00121359	1.0347461338237223
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00121359	1.0347461338237223
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00121359	1.0347461338237223
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.00121359	1.0347461338237223
SECKEL SYNDROME 2; SCKL2	0.00121359	1.0347461338237223
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00121359	1.0347461338237223
Rothmund-Thomson syndrome	0.00121359	1.0347461338237223
CORNELIA DE LANGE SYNDROME 3	0.00121359	1.0347461338237223
Smith-Magenis Syndrome	0.00121359	1.0347461338237223
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.00121359	1.0347461338237223
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.00121359	1.0347461338237223
CODAS SYNDROME	0.00121359	1.0347461338237223
245800 LAURENCE-MOON SYNDROME	0.00121359	1.0347461338237223
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00121359	1.0347461338237223
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00121359	1.0347461338237223
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00121359	1.0347461338237223
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.00121359	1.0347461338237223
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00121359	1.0347461338237223
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00121359	1.0347461338237223
Aarskog-Scott syndrome	0.00121359	1.0347461338237223
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00121359	1.0347461338237223
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00121359	1.0347461338237223
NAIL-PATELLA SYNDROME	0.00121359	1.0347461338237223
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00121359	1.0347461338237223
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00121359	1.0347461338237223
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00121359	1.0347461338237223
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00121359	1.0347461338237223
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.00121359	1.0347461338237223
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00121359	1.0347461338237223
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.00121359	1.0347461338237223
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.00121359	1.0347461338237223
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00121359	1.0347461338237223
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00121359	1.0347461338237223
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00121359	1.0347461338237223
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.00121359	1.0347461338237223
GLYCOGEN STORAGE DISEASE IA	0.00121359	1.0347461338237223
NOONAN SYNDROME 5; NS5	0.00121359	1.0347461338237223
THUMB DEFORMITY AND ALOPECIA	0.00121359	1.0347461338237223
#113100 BRACHYDACTYLY, TYPE C; BDC;;BRACHYDACTYLY, HAWS TYPE	0.00121359	1.0347461338237223
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00121359	1.0347461338237223
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00121359	1.0347461338237223
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00121359	1.0347461338237223
CROME SYNDROME	0.00121359	1.0347461338237223
PYGMY	0.00121359	1.0347461338237223
FEINGOLD SYNDROME 2; FGLDS2	0.00121359	1.0347461338237223
DYSTONIA 28, CHILDHOOD-ONSET	0.00121359	1.0347461338237223
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.00121359	1.0347461338237223
Myhre syndrome	0.00121359	1.0347461338237223
N-ACETYLASPARTATE DEFICIENCY; NACED	0.00121359	1.0347461338237223
LESCH-NYHAN SYNDROME; LNS	0.00121359	1.0347461338237223
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.00121359	1.0347461338237223
CORNELIA DE LANGE SYNDROME 1	0.00121359	1.0347461338237223
HAIRY ELBOWS	0.00121359	1.0347461338237223
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00121359	1.0347461338237223
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00121359	1.0347461338237223
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.00121359	1.0347461338237223
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00121359	1.0347461338237223
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.00121359	1.0347461338237223
MACS SYNDROME	0.00121359	1.0347461338237223
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00121359	1.0347461338237223
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.00121359	1.0347461338237223
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00121359	1.0347461338237223
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00121359	1.0347461338237223
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00121359	1.0347461338237223
RENPENNING SYNDROME 1; RENS1	0.00121359	1.0347461338237223
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00121359	1.0347461338237223
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00121359	1.0347461338237223
FONTAINE PROGEROID SYNDROME; FPS	0.00121359	1.0347461338237223
OROFACIODIGITAL SYNDROME IV; OFD4	0.00121359	1.0347461338237223
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00121359	1.0347461338237223
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00121359	1.0347461338237223
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00121359	1.0347461338237223
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00121359	1.0347461338237223
Williams-Beuren Syndrome (WBS)	0.00121359	1.0347461338237223
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00121359	1.0347461338237223
CEREBELLOFACIODENTAL SYNDROME	0.00121359	1.0347461338237223
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00121359	1.0347461338237223
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00121359	1.0347461338237223
RUIJS-AALFS SYNDROME; RJALS	0.00121359	1.0347461338237223
CHROMOSOME 17q12 DELETION SYNDROME	0.00121359	1.0347461338237223
MIRAGE SYNDROME; MIRAGE	0.00121359	1.0347461338237223
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00121359	1.0347461338237223
MEIER-GORLIN SYNDROME 7	0.00121359	1.0347461338237223
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00121359	1.0347461338237223
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.00121359	1.0347461338237223
POTOCKI-LUPSKI SYNDROME	0.00121359	1.0347461338237223
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00121359	1.0347461338237223
STIFF SKIN SYNDROME	0.00121359	1.0347461338237223
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00121359	1.0347461338237223
ANAUXETIC DYSPLASIA 2; ANXD2	0.00121359	1.0347461338237223
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.00121359	1.0347461338237223
MARINESCO-SJOGREN SYNDROME; MSS	0.00121359	1.0347461338237223
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00121359	1.0347461338237223
%613678 BRACHYOLMIA TYPE 2;;BRACHYOLMIA, MAROTEAUX TYPE	0.00121359	1.0347461338237223
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00121359	1.0347461338237223
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00121359	1.0347461338237223
MENTAL RETARDATION, X-LINKED 2	0.00121359	1.0347461338237223
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00121359	1.0347461338237223
PELIZAEUS-MERZBACHER DISEASE	0.00121359	1.0347461338237223
ACROCRANIOFACIAL DYSOSTOSIS	0.00121359	1.0347461338237223
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00121359	1.0347461338237223
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00121359	1.0347461338237223
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00121359	1.0347461338237223
STICKLER SYNDROME, TYPE V; STL5	0.00121359	1.0347461338237223
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00121359	1.0347461338237223
Orofaciodigital syndrome XVII	0.00121359	1.0347461338237223
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00121359	1.0347461338237223
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00121359	1.0347461338237223
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00121359	1.0347461338237223
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00121359	1.0347461338237223
AROMATASE EXCESS SYNDROME	0.00121359	1.0347461338237223
#112500 BRACHYDACTYLY, TYPE A1; BDA1;;FARABEE-TYPE BRACHYDACTYLY	0.00121359	1.0347461338237223
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00121359	1.0347461338237223
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00121359	1.0347461338237223
AURICULOOSTEODYSPLASIA	0.00121359	1.0347461338237223
SECKEL SYNDROME 4	0.00121359	1.0347461338237223
PRIMROSE SYNDROME; PRIMS	0.00121359	1.0347461338237223
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00121359	1.0347461338237223
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00121359	1.0347461338237223
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.00121359	1.0347461338237223
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00121359	1.0347461338237223
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00121359	1.0347461338237223
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00121359	1.0347461338237223
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.00121359	1.0347461338237223
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00121359	1.0347461338237223
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00121359	1.0347461338237223
NAVAJO NEUROHEPATOPATHY	0.00121359	1.0347461338237223
JOHANSON-BLIZZARD SYNDROME; JBS	0.00121359	1.0347461338237223
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00121359	1.0347461338237223
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.00121359	1.0347461338237223
#218030 APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	0.00121359	1.0347461338237223
3MC SYNDROME 3	0.00121359	1.0347461338237223
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00121359	1.0347461338237223
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.00121359	1.0347461338237223
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00121359	1.0347461338237223
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00121359	1.0347461338237223
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.00121359	1.0347461338237223
CULLER-JONES SYNDROME; CJS	0.00121359	1.0347461338237223
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.00121359	1.0347461338237223
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00121359	1.0347461338237223
OSTEOGENESIS IMPERFECTA, TYPE V	0.00121359	1.0347461338237223
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00121359	1.0347461338237223
MENKES DISEASE	0.00121359	1.0347461338237223
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.00121359	1.0347461338237223
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00121359	1.0347461338237223
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.00121359	1.0347461338237223
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.00121359	1.0347461338237223
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00121359	1.0347461338237223
#612650 CILIARY DYSKINESIA, PRIMARY, 12; CILD12	0.00121359	1.0347461338237223
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.00121359	1.0347461338237223
SONODA SYNDROME	0.00121359	1.0347461338237223
15q24 recurrent microdeletion syndrome	0.00121359	1.0347461338237223
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00121359	1.0347461338237223
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00121359	1.0347461338237223
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00121359	1.0347461338237223
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00121359	1.0347461338237223
GLYCOGEN STORAGE DISEASE IB	0.00121359	1.0347461338237223
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.00121359	1.0347461338237223
DIAMOND-BLACKFAN ANEMIA 10	0.00121359	1.0347461338237223
NEUROFIBROMATOSIS, TYPE I	0.00121359	1.0347461338237223
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00121359	1.0347461338237223
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00121359	1.0347461338237223
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.00121359	1.0347461338237223
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00121359	1.0347461338237223
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00121359	1.0347461338237223
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00121359	1.0347461338237223
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00121359	1.0347461338237223
RAMON SYNDROME	0.00121359	1.0347461338237223
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.00121359	1.0347461338237223
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00121359	1.0347461338237223
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00121359	1.0347461338237223
THORACOPELVIC DYSOSTOSIS	0.00121359	1.0347461338237223
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00121359	1.0347461338237223
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00121359	1.0347461338237223
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00121359	1.0347461338237223
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00121359	1.0347461338237223
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00121359	1.0347461338237223
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.00121359	1.0347461338237223
NASODIGITOACOUSTIC SYNDROME	0.00121359	1.0347461338237223
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00121359	1.0347461338237223
SAUL-WILSON SYNDROME; SWILS	0.00121359	1.0347461338237223
SIFRIM-HITZ-WEISS SYNDROME	0.00121359	1.0347461338237223
GLYCEROL KINASE DEFICIENCY; GKD	0.00121359	1.0347461338237223
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00121359	1.0347461338237223
WITTEVEEN-KOLK SYNDROME	0.00121359	1.0347461338237223
FOUNTAIN SYNDROME	0.00121359	1.0347461338237223
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00121359	1.0347461338237223
OGDEN SYNDROME; OGDNS	0.00121359	1.0347461338237223
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.00121359	1.0347461338237223
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.00121359	1.0347461338237223
OROFACIODIGITAL SYNDROME VI	0.00121359	1.0347461338237223
VELOCARDIOFACIAL SYNDROME	0.00121359	1.0347461338237223
#150250 LARSEN SYNDROME; LRS	0.00121359	1.0347461338237223
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.00121359	1.0347461338237223
PERRAULT SYNDROME 3	0.00121359	1.0347461338237223
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00121359	1.0347461338237223
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00121359	1.0347461338237223
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00121359	1.0347461338237223
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00121359	1.0347461338237223
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.00121359	1.0347461338237223
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.00121359	1.0347461338237223
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00121359	1.0347461338237223
RAPADILINO SYNDROME	0.00121359	1.0347461338237223
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00121359	1.0347461338237223
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00121359	1.0347461338237223
INCONTINENTIA PIGMENTI; IP	0.00121359	1.0347461338237223
WIDOW&#39;S PEAK SYNDROME	0.00121359	1.0347461338237223
JOUBERT SYNDROME 26	0.00121359	1.0347461338237223
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.00121359	1.0347461338237223
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.00121359	1.0347461338237223
CHROMOSOME 15q25 DELETION SYNDROME	0.00121359	1.0347461338237223
AL KAISSI SYNDROME; ALKAS	0.00121359	1.0347461338237223
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00121359	1.0347461338237223
RADIAL-RENAL SYNDROME	0.00121359	1.0347461338237223
LYMPHEDEMA, HEREDITARY, III	0.00121359	1.0347461338237223
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.00121359	1.0347461338237223
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00121359	1.0347461338237223
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00121359	1.0347461338237223
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00121359	1.0347461338237223
FLOATING-HARBOR SYNDROME	0.00121359	1.0347461338237223
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.00121359	1.0347461338237223
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.00121359	1.0347461338237223
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00121359	1.0347461338237223
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.00121359	1.0347461338237223
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00121359	1.0347461338237223
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00121359	1.0347461338237223
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00121359	1.0347461338237223
NIJMEGEN BREAKAGE SYNDROME	0.00121359	1.0347461338237223
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.00121359	1.0347461338237223
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00121359	1.0347461338237223
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00121359	1.0347461338237223
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.00121359	1.0347461338237223
CRANIOECTODERMAL DYSPLASIA 3	0.00121359	1.0347461338237223
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.00121359	1.0347461338237223
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.00121359	1.0347461338237223
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00121359	1.0347461338237223
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00121359	1.0347461338237223
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00121359	1.0347461338237223
EXOSTOSES, MULTIPLE, TYPE II	0.00121359	1.0347461338237223
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.00121359	1.0347461338237223
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.00121359	1.0347461338237223
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.00121359	1.0347461338237223
SEPTOOPTIC DYSPLASIA	0.00121359	1.0347461338237223
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00121359	1.0347461338237223
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00121359	1.0347461338237223
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00121359	1.0347461338237223
#614205 THREE M SYNDROME 3; 3M3;;3@M SYNDROME 3	0.00121359	1.0347461338237223
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00121359	1.0347461338237223
#614162 IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.00121359	1.0347461338237223
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.00121359	1.0347461338237223
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.00121359	1.0347461338237223
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00121359	1.0347461338237223
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00121359	1.0347461338237223
SHPRINTZEN OMPHALOCELE SYNDROME	0.00121359	1.0347461338237223
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00121359	1.0347461338237223
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00121359	1.0347461338237223
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00121359	1.0347461338237223
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.00121359	1.0347461338237223
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00121359	1.0347461338237223
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00121359	1.0347461338237223
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00121359	1.0347461338237223
Retinitis pigmentosa with or without skeletal anomalies	0.00121359	1.0347461338237223
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.00121359	1.0347461338237223
CRANIOFRONTONASAL SYNDROME; CFNS	0.00121359	1.0347461338237223
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.00121359	1.0347461338237223
OROFACIODIGITAL SYNDROME I; OFD1	0.00121359	1.0347461338237223
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00121359	1.0347461338237223
#259450 BRUCK SYNDROME 1; BRKS1	0.00121359	1.0347461338237223
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.00121359	1.0347461338237223
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00121359	1.0347461338237223
BRACHYDACTYLY, TYPE E2; BDE2	0.00121359	1.0347461338237223
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00121359	1.0347461338237223
CHITAYAT SYNDROME	0.00121359	1.0347461338237223
#613986 PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6	0.00121359	1.0347461338237223
HOLOPROSENCEPHALY 1; HPE1	0.00121359	1.0347461338237223
SCHIZOPHRENIA 1; SCZD1	0.00121359	1.0347461338237223
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00121359	1.0347461338237223
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.00121359	1.0347461338237223
OCULOPALATOCEREBRAL SYNDROME	0.00121359	1.0347461338237223
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00121359	1.0347461338237223
BRACHYDACTYLY, TYPE A6	0.00121359	1.0347461338237223
DENT DISEASE 1	0.00121359	1.0347461338237223
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00121359	1.0347461338237223
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.00121359	1.0347461338237223
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00121359	1.0347461338237223
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.00121359	1.0347461338237223
NEURAMINIDASE DEFICIENCY	0.00121359	1.0347461338237223
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00121359	1.0347461338237223
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.00121359	1.0347461338237223
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00121359	1.0347461338237223
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00121359	1.0347461338237223
CHROMOSOME 10Q26 DELETION SYNDROME	0.00121359	1.0347461338237223
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.00121359	1.0347461338237223
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.00121359	1.0347461338237223
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00121359	1.0347461338237223
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00121359	1.0347461338237223
KBG SYNDROME	0.00121359	1.0347461338237223
LUSCAN-LUMISH SYNDROME; LLS	0.00121359	1.0347461338237223
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00121359	1.0347461338237223
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00121359	1.0347461338237223
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.00121359	1.0347461338237223
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.00121359	1.0347461338237223
HYPERTELORISM, TEEBI TYPE; TBHS	0.00121359	1.0347461338237223
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00121359	1.0347461338237223
NOONAN SYNDROME 7; NS7	0.00121359	1.0347461338237223
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00121359	1.0347461338237223
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.00121359	1.0347461338237223
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00121359	1.0347461338237223
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00121359	1.0347461338237223
MEND SYNDROME; MEND	0.00121359	1.0347461338237223
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00121359	1.0347461338237223
BRUCK SYNDROME 2	0.00121359	1.0347461338237223
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00121359	1.0347461338237223
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.00121359	1.0347461338237223
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00121359	1.0347461338237223
ASPARTYLGLUCOSAMINURIA; AGU	0.00121359	1.0347461338237223
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.00121359	1.0347461338237223
COFFIN-LOWRY SYNDROME; CLS	0.00121359	1.0347461338237223
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00121359	1.0347461338237223
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.00121359	1.0347461338237223
LOEYS-DIETZ SYNDROME 5	0.00121359	1.0347461338237223
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00121359	1.0347461338237223
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.00121359	1.0347461338237223
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00121359	1.0347461338237223
GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	0.00121359	1.0347461338237223
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00121359	1.0347461338237223
MICROHYDRANENCEPHALY; MHAC	0.00121359	1.0347461338237223
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.00121359	1.0347461338237223
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00121359	1.0347461338237223
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00121359	1.0347461338237223
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00121359	1.0347461338237223
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00121359	1.0347461338237223
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00121359	1.0347461338237223
#278250 WRINKLY SKIN SYNDROME; WSS	0.00121359	1.0347461338237223
GLYCOGEN STORAGE DISEASE IXB	0.00121359	1.0347461338237223
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.00121359	1.0347461338237223
OPTIC ATROPHY 11; OPA11	0.00121359	1.0347461338237223
22q11.2 distal deletion syndrome	0.00121359	1.0347461338237223
CHROMOSOME 1p35 DELETION SYNDROME	0.00121359	1.0347461338237223
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00121359	1.0347461338237223
XQ25 DUPLICATION SYNDROME	0.00121359	1.0347461338237223
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00121359	1.0347461338237223
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00121359	1.0347461338237223
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00121359	1.0347461338237223
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00121359	1.0347461338237223
PYCNODYSOSTOSIS	0.00121359	1.0347461338237223
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00121359	1.0347461338237223
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00121359	1.0347461338237223
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00121359	1.0347461338237223
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00121359	1.0347461338237223
Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	0.00121359	1.0347461338237223
DESBUQUOIS DYSPLASIA 2; DBQD2	0.00121359	1.0347461338237223
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00121359	1.0347461338237223
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00121359	1.0347461338237223
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.00121359	1.0347461338237223
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00121359	1.0347461338237223
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.00121359	1.0347461338237223
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.00121359	1.0347461338237223
SJOGREN-LARSSON SYNDROME; SLS	0.00121359	1.0347461338237223
2q33.1 deletion syndrome	0.00121359	1.0347461338237223
#226670 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY;;EBS-MD;;EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY;;MD-EBS; MDEBS	0.00121359	1.0347461338237223
THREE M SYNDROME 2; 3M2	0.00121359	1.0347461338237223
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00121359	1.0347461338237223
CHROMOSOME 18P DELETION SYNDROME	0.00121359	1.0347461338237223
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00121359	1.0347461338237223
KEARNS-SAYRE SYNDROME; KSS	0.00121359	1.0347461338237223
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00121359	1.0347461338237223
DIAMOND-BLACKFAN ANEMIA 5	0.00121359	1.0347461338237223
ALAZAMI-YUAN SYNDROME	0.00121359	1.0347461338237223
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00121359	1.0347461338237223
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.00121359	1.0347461338237223
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00121359	1.0347461338237223
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00121359	1.0347461338237223
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00121359	1.0347461338237223
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00121359	1.0347461338237223
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00121359	1.0347461338237223
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.00121359	1.0347461338237223
GURRIERI SYNDROME	0.00121359	1.0347461338237223
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00121359	1.0347461338237223
#615503 SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	0.00121359	1.0347461338237223
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00121359	1.0347461338237223
COFFIN-SIRIS SYNDROME 5	0.00121359	1.0347461338237223
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.00121359	1.0347461338237223
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00121359	1.0347461338237223
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.00121359	1.0347461338237223
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00121359	1.0347461338237223
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00121359	1.0347461338237223
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00121359	1.0347461338237223
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.00121359	1.0347461338237223
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.00121359	1.0347461338237223
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00121359	1.0347461338237223
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00121359	1.0347461338237223
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00121359	1.0347461338237223
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00121359	1.0347461338237223
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00121359	1.0347461338237223
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00121359	1.0347461338237223
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00121359	1.0347461338237223
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00121359	1.0347461338237223
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00121359	1.0347461338237223
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.00121359	1.0347461338237223
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.00121359	1.0347461338237223
MUCOLIPIDOSIS III ALPHA/BETA	0.00121359	1.0347461338237223
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00121359	1.0347461338237223
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00121359	1.0347461338237223
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00121359	1.0347461338237223
NOONAN SYNDROME 8; NS8	0.00121359	1.0347461338237223
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.00121359	1.0347461338237223
OHDO SYNDROME	0.00121359	1.0347461338237223
MICROPHTHALMIA, SYNDROMIC 3	0.00121359	1.0347461338237223
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00121359	1.0347461338237223
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.00121359	1.0347461338237223
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00121359	1.0347461338237223
#615072 BRACHYDACTYLY, TYPE A1, C; BDA1C	0.00121359	1.0347461338237223
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00121359	1.0347461338237223
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00121359	1.0347461338237223
Mental retardation, autosomal dominant 21	0.00121359	1.0347461338237223
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.00121359	1.0347461338237223
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.00121359	1.0347461338237223
HUNTER-MACDONALD SYNDROME	0.00121359	1.0347461338237223
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.00121359	1.0347461338237223
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00121359	1.0347461338237223
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00121359	1.0347461338237223
PELVIS-SHOULDER DYSPLASIA	0.00121359	1.0347461338237223
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00121359	1.0347461338237223
SACCHAROPINURIA	0.00121359	1.0347461338237223
OSTEOGENESIS IMPERFECTA, TYPE X	0.00121359	1.0347461338237223
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.00121359	1.0347461338237223
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.00121359	1.0347461338237223
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.00121359	1.0347461338237223
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00121359	1.0347461338237223
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00121359	1.0347461338237223
SAY SYNDROME	0.00121359	1.0347461338237223
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.00121359	1.0347461338237223
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.00121359	1.0347461338237223
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00121359	1.0347461338237223
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.00121359	1.0347461338237223
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.00121359	1.0347461338237223
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00121359	1.0347461338237223
C SYNDROME	0.00121359	1.0347461338237223
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.00121359	1.0347461338237223
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00121359	1.0347461338237223
NOONAN SYNDROME 4; NS4	0.00121359	1.0347461338237223
PRADER-WILLI SYNDROME; PWS	0.00121359	1.0347461338237223
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.00121359	1.0347461338237223
SPASTIC PARAPARESIS AND DEAFNESS	0.00121359	1.0347461338237223
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.00121359	1.0347461338237223
MENTAL RETARDATION, X-LINKED 45	0.00121359	1.0347461338237223
RUVALCABA SYNDROME	0.00121359	1.0347461338237223
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00121359	1.0347461338237223
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.00121359	1.0347461338237223
#300867 KABUKI SYNDROME 2; KABUK2	0.00121359	1.0347461338237223
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.00121359	1.0347461338237223
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.00121359	1.0347461338237223
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.00121359	1.0347461338237223
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00121359	1.0347461338237223
RHYNS SYNDROME; RHYNS	0.00121359	1.0347461338237223
STORMORKEN SYNDROME; STRMK	0.00121359	1.0347461338237223
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00121359	1.0347461338237223
EIKEN SYNDROME	0.00121359	1.0347461338237223
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00121359	1.0347461338237223
SPONDYLOOCULAR SYNDROME; SOS	0.00121359	1.0347461338237223
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00121359	1.0347461338237223
MENTAL RETARDATION, X-LINKED 99	0.00121359	1.0347461338237223
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.00121359	1.0347461338237223
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.00121359	1.0347461338237223
FRIAS SYNDROME	0.00121359	1.0347461338237223
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.00121359	1.0347461338237223
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.00121359	1.0347461338237223
GLASS SYNDROME	0.00121359	1.0347461338237223
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.00121359	1.0347461338237223
Potocki-Lupski syndrome (17p11.2 duplication syndrome)	0.00121359	1.0347461338237223
600736 VELOFACIOSKELETAL SYNDROME	0.00121359	1.0347461338237223
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00121359	1.0347461338237223
#300582 SHORT STATURE, IDIOPATHIC, X-LINKED; ISS	0.00121359	1.0347461338237223
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00121359	1.0347461338237223
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.00121359	1.0347461338237223
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00121359	1.0347461338237223
OROFACIODIGITAL SYNDROME IX; OFD9	0.00121359	1.0347461338237223
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00121359	1.0347461338237223
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.00121359	1.0347461338237223
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00121359	1.0347461338237223
SPINAL DYSPLASIA, ANHALT TYPE	0.00121359	1.0347461338237223
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00121359	1.0347461338237223
AYME-GRIPP SYNDROME; AYGRP	0.00121359	1.0347461338237223
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00121359	1.0347461338237223
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.00121359	1.0347461338237223
WERNER SYNDROME; WRN	0.00121359	1.0347461338237223
EHLERS-DANLOS SYNDROME, TYPE I	0.00121359	1.0347461338237223
IMMUNODEFICIENCY 36; IMD36	0.00121359	1.0347461338237223
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00121359	1.0347461338237223
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.00121359	1.0347461338237223
IMMUNODEFICIENCY 55; IMD55	0.00121359	1.0347461338237223
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.00121359	1.0347461338237223
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00121359	1.0347461338237223
TRICHOHEPATOENTERIC SYNDROME 1	0.00121359	1.0347461338237223
CHROMOSOME 2q37 DELETION SYNDROME	0.00121359	1.0347461338237223
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.00121359	1.0347461338237223
LISSENCEPHALY 4	0.00121359	1.0347461338237223
#611554 LEOPARD SYNDROME 2	0.00121359	1.0347461338237223
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.00121359	1.0347461338237223
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00121359	1.0347461338237223
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00121359	1.0347461338237223
#154780 MARSHALL SYNDROME; MRSHS	0.00121359	1.0347461338237223
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00121359	1.0347461338237223
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00121359	1.0347461338237223
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00121359	1.0347461338237223
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00121359	1.0347461338237223
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.00121359	1.0347461338237223
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00121359	1.0347461338237223
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00121359	1.0347461338237223
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.00121359	1.0347461338237223
ZTTK SYNDROME; ZTTKS	0.00121359	1.0347461338237223
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00121359	1.0347461338237223
LEGG-CALVE-PERTHES DISEASE	0.00121359	1.0347461338237223
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.00121359	1.0347461338237223
CHARGE-LIKE SYNDROME, X-LINKED	0.00121359	1.0347461338237223
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.00121359	1.0347461338237223
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00121359	1.0347461338237223
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00121359	1.0347461338237223
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00121359	1.0347461338237223
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.00121359	1.0347461338237223
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00121359	1.0347461338237223
EXOSTOSES, MULTIPLE, TYPE I	0.00121359	1.0347461338237223
SATOYOSHI SYNDROME	0.00121359	1.0347461338237223
NOONAN SYNDROME 9; NS9	0.00121359	1.0347461338237223
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00121359	1.0347461338237223
NEPHROTIC SYNDROME, TYPE 17; NPHS17	0.00121359	1.0347461338237223
MASA SYNDROME	0.00121359	1.0347461338237223
#613388 FANCONI RENOTUBULAR SYNDROME 2; FRTS2	0.00121359	1.0347461338237223
SECKEL SYNDROME 5; SCKL5	0.00121359	1.0347461338237223
BIEMOND SYNDROME II	0.00121359	1.0347461338237223
STUVE-WIEDEMANN SYNDROME	0.00121359	1.0347461338237223
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00121359	1.0347461338237223
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.00121359	1.0347461338237223
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00121359	1.0347461338237223
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00121359	1.0347461338237223
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00121359	1.0347461338237223
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00121359	1.0347461338237223
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00121359	1.0347461338237223
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00121359	1.0347461338237223
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00121359	1.0347461338237223
#615139 FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS	0.00121359	1.0347461338237223
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.00121359	1.0347461338237223
FANCONI ANEMIA	0.00121359	1.0347461338237223
FOCAL DERMAL HYPOPLASIA; FDH	0.00121359	1.0347461338237223
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00121359	1.0347461338237223
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00121359	1.0347461338237223
#615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3	0.00121359	1.0347461338237223
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00121359	1.0347461338237223
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.00121359	1.0347461338237223
MARTSOLF SYNDROME	0.00121359	1.0347461338237223
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00121359	1.0347461338237223
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.00121359	1.0347461338237223
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00121359	1.0347461338237223
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00121359	1.0347461338237223
MCDONOUGH SYNDROME	0.00121359	1.0347461338237223
RODRIGUES BLINDNESS	0.00121359	1.0347461338237223
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00121359	1.0347461338237223
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00121359	1.0347461338237223
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00121359	1.0347461338237223
FORSYTHE-WAKELING SYNDROME; FWS	0.00121359	1.0347461338237223
#614728 SECKEL SYNDROME 6; SCKL6	0.00121359	1.0347461338237223
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00121359	1.0347461338237223
CHOPS SYNDROME; CHOPS	0.00121359	1.0347461338237223
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00121359	1.0347461338237223
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00121359	1.0347461338237223
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00121359	1.0347461338237223
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.00121359	1.0347461338237223
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00121359	1.0347461338237223
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00121359	1.0347461338237223
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00121359	1.0347461338237223
KOOLEN-DE VRIES SYNDROME; KDVS	0.00121359	1.0347461338237223
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.00121359	1.0347461338237223
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00121359	1.0347461338237223
WATSON SYNDROME	0.00121359	1.0347461338237223
DIAMOND-BLACKFAN ANEMIA 4	0.00121359	1.0347461338237223
HYPOPHOSPHATEMIC BONE DISEASE	0.00121359	1.0347461338237223
#613707 LEOPARD SYNDROME 3; LPRD3	0.00121359	1.0347461338237223
Trichothiodystrophy 5, nonphotosensitive	0.00121359	1.0347461338237223
KENNERKNECHT SYNDROME	0.00121359	1.0347461338237223
#604864 OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA	0.00121359	1.0347461338237223
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00121359	1.0347461338237223
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.00121359	1.0347461338237223
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00121359	1.0347461338237223
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.00121359	1.0347461338237223
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00121359	1.0347461338237223
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.00121359	1.0347461338237223
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.00121359	1.0347461338237223
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00121359	1.0347461338237223
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.00121359	1.0347461338237223
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00121359	1.0347461338237223
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.00121359	1.0347461338237223
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.00121359	1.0347461338237223
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00121359	1.0347461338237223
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.00121359	1.0347461338237223
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.00121359	1.0347461338237223
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00121359	1.0347461338237223
DIAMOND-BLACKFAN ANEMIA 8	0.00121359	1.0347461338237223
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00121359	1.0347461338237223
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00121359	1.0347461338237223
NOONAN SYNDROME 3; NS3	0.00121359	1.0347461338237223
DIGEORGE SYNDROME; DGS	0.00121359	1.0347461338237223
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00121359	1.0347461338237223
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00121359	1.0347461338237223
TEEBI-SHALTOUT SYNDROME; TBSH	0.00121359	1.0347461338237223
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00121359	1.0347461338237223
#276880 UROCANASE DEFICIENCY	0.00121359	1.0347461338237223
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00121359	1.0347461338237223
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00121359	1.0347461338237223
HARTNUP DISORDER	0.00121359	1.0347461338237223
HADZISELIMOVIC SYNDROME	0.00121359	1.0347461338237223
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.00121359	1.0347461338237223
NIEMANN-PICK DISEASE, TYPE B	0.00121359	1.0347461338237223
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00121359	1.0347461338237223
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00121359	1.0347461338237223
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00121359	1.0347461338237223
PALLISTER-HALL SYNDROME	0.00121359	1.0347461338237223
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00121359	1.0347461338237223
260150 PALANT CLEFT PALATE SYNDROME	0.00121359	1.0347461338237223
WIEACKER-WOLFF SYNDROME	0.00121359	1.0347461338237223
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00121359	1.0347461338237223
OVARIAN DYSGENESIS 5; ODG5	0.00121359	1.0347461338237223
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00121359	1.0347461338237223
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00121359	1.0347461338237223
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.00121359	1.0347461338237223
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00121359	1.0347461338237223
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00121359	1.0347461338237223
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00121359	1.0347461338237223
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00121359	1.0347461338237223
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00121359	1.0347461338237223
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00121359	1.0347461338237223
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00121359	1.0347461338237223
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00121359	1.0347461338237223
GRACILE BONE DYSPLASIA; GCLEB	0.00121359	1.0347461338237223
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.00121359	1.0347461338237223
Cat-Eye Syndrome (Type I)	0.00121359	1.0347461338237223
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00121359	1.0347461338237223
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.00121359	1.0347461338237223
608028 THAI SYMPHALANGISM SYNDROME	0.00121359	1.0347461338237223
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.00121359	1.0347461338237223
#186570 TARSAL-CARPAL COALITION SYNDROME; TCC; SYNOSTOSIS OF TALUS AND CALCANEUS WITH SHORT STATURE, INCLUDED	0.00121359	1.0347461338237223
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00121359	1.0347461338237223
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00121359	1.0347461338237223
WEILL-MARCHESANI SYNDROME 3	0.00121359	1.0347461338237223
LATERAL MENINGOCELE SYNDROME	0.00121359	1.0347461338237223
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00121359	1.0347461338237223
HYPOPHOSPHATASIA, CHILDHOOD	0.00121359	1.0347461338237223
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.00121359	1.0347461338237223
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00121359	1.0347461338237223
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00121359	1.0347461338237223
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00121359	1.0347461338237223
HURLER-SCHEIE SYNDROME	0.00121359	1.0347461338237223
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.00121359	1.0347461338237223
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00121359	1.0347461338237223
WARBURG MICRO SYNDROME 1	0.00121359	1.0347461338237223
NOONAN SYNDROME 2; NS2	0.00121359	1.0347461338237223
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00121359	1.0347461338237223
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00121359	1.0347461338237223
PRECOCIOUS PUBERTY, CENTRAL	0.00121359	1.0347461338237223
Pierpont syndrome	0.00121359	1.0347461338237223
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00121359	1.0347461338237223
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.00121359	1.0347461338237223
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.00121359	1.0347461338237223
MENTAL RETARDATION, X-LINKED 92	0.00121359	1.0347461338237223
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00121359	1.0347461338237223
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00121359	1.0347461338237223
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00121359	1.0347461338237223
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00121359	1.0347461338237223
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00121359	1.0347461338237223
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.00121359	1.0347461338237223
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00121359	1.0347461338237223
MENTAL RETARDATION, X-LINKED 84	0.00121359	1.0347461338237223
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00121359	1.0347461338237223
OVARIAN DYSGENESIS 4; ODG4	0.00121359	1.0347461338237223
HURLER SYNDROME	0.00121359	1.0347461338237223
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00121359	1.0347461338237223
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00121359	1.0347461338237223
#612781 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B;;IGHD IB;;DWARFISM OF SINDH	0.00121359	1.0347461338237223
BOHRING-OPITZ SYNDROME	0.00121359	1.0347461338237223
KABUKI SYNDROME 1	0.00121359	1.0347461338237223
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00121359	1.0347461338237223
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00121359	1.0347461338237223
SECKEL SYNDROME 8; SCKL8	0.00121359	1.0347461338237223
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.00121359	1.0347461338237223
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.00121359	1.0347461338237223
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.00121359	1.0347461338237223
COXOAURICULAR SYNDROME	0.00121359	1.0347461338237223
POPOV-CHANG SYNDROME; POPCHAS	0.00121359	1.0347461338237223
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00121359	1.0347461338237223
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00121359	1.0347461338237223
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00121359	1.0347461338237223
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00121359	1.0347461338237223
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00121359	1.0347461338237223
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00121359	1.0347461338237223
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00121359	1.0347461338237223
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00121359	1.0347461338237223
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00121359	1.0347461338237223
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.00121359	1.0347461338237223
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00121359	1.0347461338237223
